Reference data : LOINC code

Filter


Clear filter

Results
104,672 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType DefinitionDescription dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
20484-2 Cardiolipin Ab.IgG Titr Ser Pt SemiQn     ACTIVE Cardiolipin IgG Ab [Titer] in Serum   MAJ DefinitionDescription     titer             COAG   20484-2         Both       0 Cardiolipin IgG Titr Ser       Y   ABS; Aby; ACA; aCL; Antby; Anti; Antibodies; Antibody; Anticardiolipin; Autoantibodies; Autoantibody; Cardio; Cardiolip; Cardiolipn; Cardiolpn; CL; COAGULATION; Dilution factor; Dilution Factor (Titer); Hematology; Heme; Immune globulin G; Immunoglobulin G; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr 2.75 1.0m               {titer}       0
20485-9 Cardiolipin Ab.IgM Titr Ser Pt SemiQn     ACTIVE Cardiolipin IgM Ab [Titer] in Serum   MAJ DefinitionDescription     titer             COAG   20485-9         Both       0 Cardiolipin IgM Titr Ser       Y   ABS; Aby; ACA; aCL; Antby; Anti; Antibodies; Antibody; Anticardiolipin; Autoantibodies; Autoantibody; Cardio; Cardiolip; Cardiolipn; Cardiolpn; CL; COAGULATION; Dilution factor; Dilution Factor (Titer); Hematology; Heme; Immune globulin M; Immunoglobulin M; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr 2.75 1.0m               {titer}       0
20486-7 Haemophilus influenzae B Ag ACnc CSF Pt Qn     ACTIVE Haemophilus influenzae B Ag [Units/volume] in Cerebral spinal fluid   MIN DefinitionDescription                   MICRO   20486-7         Both       0 Haem influ B Ag CSF-aCnc       Y   Antigen; Antigens; Arbitrary concentration; Cerebral spinal fluid; Cerebrospinal Fl; H flu; H influenza; H influenzae; Haem influ; Haem influ B; Haemoph; HIB; ID; Infectious Disease; InfectiousDisease; Influ; Microbiology; Neuro; Neurology; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid 2.69 1.0m               [arb'U]/mL       0
20487-5 Neisseria meningitidis serogroups A+Y Ag PrThr CSF Pt Ord     ACTIVE Neisseria meningitidis serogroups A+Y Ag [Presence] in Cerebral spinal fluid   NAM DefinitionDescription                   MICRO   20487-5         Both       0 N men sg A+Y Ag CSF Ql           Antigen; Antigens; Cerebral spinal fluid; Cerebrospinal Fl; ID; Infectious Disease; InfectiousDisease; Mening; Meningid; Meningitis; Meningo; Meningococcal meningitis; Meningococcus; Microbiology; N men; N men sg A+Y; N men sg A+Y Ag; N menigitidis; N meningitidis; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid 2.64 1.0m                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 'serogroup'added to the Component for clarification. 0
20488-3 Streptococcus agalactiae Ag PrThr CSF Pt Ord     ACTIVE Streptococcus agalactiae Ag [Presence] in Cerebral spinal fluid   MIN DefinitionDescription                   MICRO   20488-3         Both       0 Gp B Strep Ag CSF Ql           Antigen; Antigens; Cerebral spinal fluid; Cerebrospinal Fl; GBS; Gp B Strep; Group B; Group B Strep; ID; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; S agalactiae; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Steptococcus Group B; Strep; Strep B; Strep group B; Strept; Streptococci group B 2.73 1.0m                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
20489-1 Streptococcus pneumoniae Ag PrThr CSF Pt Ord     ACTIVE Streptococcus pneumoniae Ag [Presence] in Cerebral spinal fluid   MIN DefinitionDescription                   MICRO   20489-1         Both       0 S pneum Ag CSF Ql           Antigen; Antigens; Cerebral spinal fluid; Cerebrospinal Fl; ID; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Ordinal; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PR; QL; Qual; Qualitative; Random; S pneumo; S pneumoniae; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Spn; Strep; Strept 2.73 1.0m                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
2049-5 Carnosine PrThr Ser/Plas Pt Ord     ACTIVE Carnosine [Presence] in Serum or Plasma   MIN DefinitionDescription                   CHEM   2049-5         Observation       0 Carnosine SerPl Ql           Car; Chemistry; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.73 1                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
20490-9 Epstein Barr virus capsid Ab.IgG Titr Ser Pt SemiQn     ACTIVE Epstein Barr virus capsid IgG Ab [Titer] in Serum   MAJ DefinitionDescription     titer             MICRO   20490-9         Both       0 EBV VCA IgG Titr Ser       Y   ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CAP; Dilution factor; Dilution Factor (Titer); EBV; EBV capsid Ab; EBV VCA; Epstn; HHV-4; human herpesvirus 4; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Mono; Mononucleosis; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr; VCA; Viral capsid 2.75 1.0m               {titer}       0
20491-7 Epstein Barr virus capsid Ab.IgM Titr Ser Pt SemiQn     ACTIVE Epstein Barr virus capsid IgM Ab [Titer] in Serum   MAJ DefinitionDescription     titer             MICRO   20491-7         Both       0 EBV VCA IgM Titr Ser       Y   ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CAP; Dilution factor; Dilution Factor (Titer); EBV; EBV capsid Ab; EBV VCA; Epstn; HHV-4; human herpesvirus 4; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Mono; Mononucleosis; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr; VCA; Viral capsid 2.75 1.0m               {titer}       0
20492-5 Hemoglobin pattern imp Imp Bld Pt Qn Electrophoresis   DEPRECATED Deprecated Hemoglobin pattern [interpretation] in Blood by Electrophoresis Narrative   DEL DefinitionDescription                   HEM/BC   20492-5   Electrophoresis     Observation       0 Deprecated Hgb Bld Elph-Imp           Blood; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Hgb Fract; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood 2.36 1.0m       AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
20493-3 Histiocytes/Cells NFr Body fld Pt Qn Microscopy.light   ACTIVE Histiocytes/cells in Body fluid by Light microscopy   NAM DefinitionDescription     %             HEM/BC   20493-3   Microscopy.light     Observation       0 Histiocytes NFr Fld Micro       Y   B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cell; Cellularity; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Histiocyte; Histocytes; LM; Micro; Micros; Microscopic; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random 2.79 1.0m               %     Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; 0
20494-1 Lymphocytes/100 leukocytes NFr Body fld Pt Qn Manual count   DEPRECATED Deprecated Lymphocytes/100 leukocytes in Body fluid by Manual count   DEL DefinitionDescription     %             HEM/BC   20494-1   Manual count     Observation       0 Deprecated Lymphocytes Fr Fld Manual           100WBC; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Lymp; Lymph; Lympho; Lymphocyte; Lymphs; Lymphs%; Manl; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells 2.36 1.0m       AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
20495-8 Gliadin Ab.IgA ACnc Ser Pt Qn IA   ACTIVE Gliadin IgA Ab [Units/volume] in Serum by Immunoassay   MIN DefinitionDescription     kEU/L             SERO   20495-8   IA     Both       0 Gliadin IgA Ser IA-aCnc       Y   ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Celiac disease; EIA; ELFA; ELISA; Enzyme immunoassay; F98; Gliadine; IAA; Immune globulin A; Immunoglobulin A; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS; UniversalLabOrders 2.73 1.0m               [arb'U]/L     The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. 0
20496-6 Gliadin Ab.IgG ACnc Ser Pt Qn IA   ACTIVE Gliadin IgG Ab [Units/volume] in Serum by Immunoassay   MIN DefinitionDescription     kEU/L             SERO   20496-6   IA     Both       0 Gliadin IgG Ser IA-aCnc       Y   ABS; Aby; Agf98; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Celiac disease; EIA; ELFA; ELISA; Enzyme immunoassay; F98; Gliadine; IAA; Immune globulin G; Immunoglobulin G; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS; UniversalLabOrders 2.73 1.0m               [arb'U]/L     The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. 0
20497-4 Histoplasma capsulatum mycelial phase Ab ACnc Ser Pt Qn Comp fix   ACTIVE Histoplasma capsulatum mycelial phase Ab [Units/volume] in Serum by Complement fixation   MIN DefinitionDescription                   MICRO   20497-4   Comp fix     Both       0 H capsul Myc Ab Ser CF-aCnc       Y   ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; CF; Comp fixation; Compfix; Complement fixation; H capsul; H capsul Myc; H capsulatum; H farciminosum; Histo; Histopl; Histoplasma farciminosum; Histoplasmin; Histoplasmos; Histoplasmosis; ID; Infectious Disease; InfectiousDisease; Microbiology; Mycel; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR 2.69 1.0m               [arb'U]/mL       0
20498-2 Histoplasma capsulatum yeast phase Ab ACnc Ser Pt Qn Comp fix   ACTIVE Histoplasma capsulatum yeast phase Ab [Units/volume] in Serum by Complement fixation   MIN DefinitionDescription                   MICRO   20498-2   Comp fix     Both       0 H capsul Yst Ab Ser CF-aCnc       Y   ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; CF; Comp fixation; Compfix; Complement fixation; H capsul; H capsul Yst; H capsulatum; H farciminosum; Histo; Histopl; Histoplasma farciminosum; Histoplasmos; Histoplasmosis; ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR 2.69 1.0m               [arb'U]/mL       0
20499-0 Phosphatidylglycerol/Surfactant.total MFr Amnio fld Pt Qn     ACTIVE Phosphatidylglycerol/Surfactant.total in Amniotic fluid   MIN DefinitionDescription     %             CHEM   20499-0         Observation       0 PG MFr Amn       Y   AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Chemistry; Fetal lung maturity; Mass fraction; Percent; PG; Phosphatidyl Glycerol; Phosphotidylglycerol; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl 2.73 1.0m               %       0
205-5 Colistin Susc Isolate Pt OrdQn MIC   ACTIVE Colistin [Susceptibility] by Minimum inhibitory concentration (MIC)   MIN DefinitionDescription                   ABXBACT   205-5   MIC     Observation       0 Colistin Islt MIC           ANTIBIOTIC SUSCEPTIBILITIES; AST; Colmycin; Colymycin; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty 2.73 1                       0
2050-3 Carnosine MCnc Ser/Plas Pt Qn     DISCOURAGED Carnosine [Mass/volume] in Serum or Plasma   MIN DefinitionDescription                   CHEM   2050-3         Observation       0 Carnosine SerPl-mCnc       Y   Car; Chemistry; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.44 1       AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
20500-5 Hydroxyalprazolam MCnc Urine Pt Qn Confirm   ACTIVE Hydroxyalprazolam [Mass/volume] in Urine by Confirmatory method   MIN DefinitionDescription     ng/mL             DRUG/TOX   20500-5   Confirm     Both       0 OH-Alpraz Ur Cfm-mCnc       Y   Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Hydroxy alprazolam; Hydroxyalpraz; LC/MS/MS; Level; Mass concentration; OH-Alpraz; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn 2.73 1.0m               ng/mL       0
20501-3 Hydroxytriazolam MCnc Urine Pt Qn Confirm   ACTIVE Hydroxytriazolam [Mass/volume] in Urine by Confirmatory method   MIN DefinitionDescription     ng/mL             DRUG/TOX   20501-3   Confirm     Both       0 OH-Triazolam Ur Cfm-mCnc       Y   Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Hydroxy triazolam; Illicit; LC/MS/MS; Level; Mass concentration; OH-Triazolam; OHTRZ; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Triazolam metabolite; UA; UR; Urn 2.73 1.0m               ng/mL       0
20502-1 Clue cells PrThr Vag Pt Ord Wet preparation   ACTIVE Clue cells [Presence] in Vaginal fluid by Wet preparation   MIN DefinitionDescription                   MICRO   20502-1   Wet preparation     Both       0 Clue Cells Vag Ql Wet Prep           Cell; Cellularity; Genital vaginal; Gyn; Gynecology; ID; Infectious Disease; InfectiousDisease; Microbiology; OB; ObGyn; Obstetrics; Ordinal; Point in time; PR; Prep; QL; Qual; Qualitative; Random; Screen; Vag fld; Vag fluid; Vagina; Vaginal fluid; Vaginosis; Wet mount; Wet prep 2.73 1.0m                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
20503-9 Cells.CD22+CD11c+/Cells NFr Bld Pt Qn     ACTIVE CD22+CD11c+ cells/cells in Blood   NAM DefinitionDescription     %             CELLMARK   20503-9         Observation       0 CD22+CD11c+ Cells NFr Bld       Y   AlphaX integrin chain; Axb2; B3; B-3; BL-CAM; Blood; CD22 Cells; CD22+CD11c+ Cells; Cell; CELL MARKERS; Cellularity; CR4; Leu14; Leu-14; leukocyte surface antigen p150,95; LeuM5; Leu-M5; Lyb8; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; To-15; WB; Whole blood 2.79 1.0m               %     Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; 0
20504-7 Histiocytes/Cells NFr CSF Pt Qn     ACTIVE Histiocytes/cells in Cerebral spinal fluid   NAM DefinitionDescription     %             HEM/BC   20504-7         Observation       0 Histiocytes NFr CSF       Y   Cell; Cellularity; Cerebral spinal fluid; Cerebrospinal Fl; HEMATOLOGY/CELL COUNTS; Histiocyte; Histocytes; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid 2.79 1.0m               %     Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; 0
20505-4 Bilirubin MCnc Urine Pt SemiQn Test strip   ACTIVE Bilirubin.total [Mass/volume] in Urine by Test strip   MAJ DefinitionDescription     mg/dL             UA   20505-4   Test strip     Observation       0 Bilirub Ur Strip-mCnc       Y   Bili; Bilirubins; Billirubin; Dip stick; Dipstick; Level; Mass concentration; Point in time; Random; SmQn; TBIL; UA; UR; URINALYSIS; Urn 2.75 1.0m               mg/dL       0
104,672 results found